Regression and inhibition of sarcoma growth by interference with a radiosensitive T-cell population - PubMed (original) (raw)
Regression and inhibition of sarcoma growth by interference with a radiosensitive T-cell population
K E Hellström et al. J Exp Med. 1978.
Abstract
BALB/c mice were inoculated subcutaneously with 10(6) cells from either of two syngeneic sarcomas 1315 and 1425. 6--8 days later, the mice were randomized into groups which were left untreated or given 400 rads of whole body irradiation. Irradiation significantly retarded the growth of both sarcomas, and complete regressions were seen of approximately equal to 30% of the small, established 1315 tumors. The anti-tumor effect of irradiation was abolished if the irradiated mice were inoculated with a T-cell-enriched (but not with a T-cell deprived) suspension of syngeneic spleen cells, suggesting that the irradiation inhibited tumor growth by affecting a radiosensitive population of host suppressor T cells.
Similar articles
- Tumor-enhancing suppressor activator T cells in spleens and thymuses of tumor immune mice.
Hellström I, Hellström KE, Bernstein ID. Hellström I, et al. Proc Natl Acad Sci U S A. 1979 Oct;76(10):5294-8. doi: 10.1073/pnas.76.10.5294. Proc Natl Acad Sci U S A. 1979. PMID: 315560 Free PMC article. - Evidence that tumor antigens enhance tumor growth in vivo by interacting with a radiosensitive (suppressor?) cell population.
Hellström KE, Hellström I. Hellström KE, et al. Proc Natl Acad Sci U S A. 1978 Jan;75(1):436-40. doi: 10.1073/pnas.75.1.436. Proc Natl Acad Sci U S A. 1978. PMID: 272660 Free PMC article. - Antitumor effect of whole-body X-irradiation: possible role of an X-ray-sensitive T suppressor cell population.
Hellström I, Hellström KE. Hellström I, et al. Transplant Proc. 1979 Mar;11(1):1073-6. Transplant Proc. 1979. PMID: 313092 - Radiosensitive barrier to T-cell-mediated adoptive immunotherapy of established tumors.
Awwad M, North RJ. Awwad M, et al. Cancer Res. 1990 Apr 15;50(8):2228-33. Cancer Res. 1990. PMID: 2317810 - Immunosuppression as a homeostatic mechanism in disease and aging.
Strausser HR, Rosenstein MM. Strausser HR, et al. Adv Exp Med Biol. 1979;121B:277-81. doi: 10.1007/978-1-4684-8914-9_26. Adv Exp Med Biol. 1979. PMID: 397750 Review. No abstract available.
Cited by
- Immunosuppression in murine renal cell carcinoma. II. Identification of responsible lymphoid cell phenotypes and examination of elimination of suppression.
Gregorian SK, Battisto JR. Gregorian SK, et al. Cancer Immunol Immunother. 1990;31(6):335-41. doi: 10.1007/BF01741404. Cancer Immunol Immunother. 1990. PMID: 1974826 Free PMC article. - Harnessing the Microbiome to Enhance Cancer Immunotherapy.
Nelson MH, Diven MA, Huff LW, Paulos CM. Nelson MH, et al. J Immunol Res. 2015;2015:368736. doi: 10.1155/2015/368736. Epub 2015 May 25. J Immunol Res. 2015. PMID: 26101781 Free PMC article. Review. - Tumor-enhancing suppressor activator T cells in spleens and thymuses of tumor immune mice.
Hellström I, Hellström KE, Bernstein ID. Hellström I, et al. Proc Natl Acad Sci U S A. 1979 Oct;76(10):5294-8. doi: 10.1073/pnas.76.10.5294. Proc Natl Acad Sci U S A. 1979. PMID: 315560 Free PMC article. - Reduced tumor growth after low-dose irradiation or immunization against blastic suppressor T cells.
Tilkin AF, Schaaf-Lafontaine N, Van Acker A, Boccadoro M, Urbain J. Tilkin AF, et al. Proc Natl Acad Sci U S A. 1981 Mar;78(3):1809-12. doi: 10.1073/pnas.78.3.1809. Proc Natl Acad Sci U S A. 1981. PMID: 6453350 Free PMC article. - Strategies to overcome tumour relapse caused by antigen escape after CAR T therapy.
Lu Y, Zhao F. Lu Y, et al. Mol Cancer. 2025 Apr 28;24(1):126. doi: 10.1186/s12943-025-02334-6. Mol Cancer. 2025. PMID: 40289115 Free PMC article. Review.
References
- Int J Cancer. 1978 Mar 15;21(3):317-22 - PubMed
- J Immunol. 1977 Aug;119(2):757-64 - PubMed
- Proc Natl Acad Sci U S A. 1978 Feb;75(2):955-8 - PubMed
- Proc Natl Acad Sci U S A. 1977 Jul;74(7):2989-92 - PubMed
- J Exp Med. 1977 Feb 1;145(2):455-9 - PubMed